Sign in

CIK 0000899923

  • Accelerated filer

MYRIAD GENETICS INC

Sign in to watch
Ticker
MYGN
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
870494517
Phone
+1 801-584-3600
Business address
322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
Former names
MYRIAD GENETICS INC
  1. 4 Shares withheld for taxes President and CEO gave up 30,610 shares (to pay taxes)
  2. 4 Shares withheld for taxes Chief People Officer gave up 1,108 shares (to pay taxes)
  3. 4 Shares withheld for taxes Chief Technology Officer gave up 881 shares (to pay taxes)
  4. 4 Shares withheld for taxes SVP, Chief of Staff gave up 2,231 shares (to pay taxes)
  5. 4 Insider Changes in Ownership
  6. 4 Grant or award Chief Financial Officer acquired 117,770 shares (grant or award)
  7. 3 Insider Initial Statement of Ownership
  8. 4 Shares withheld for taxes Chief Scientific Officer gave up 303 shares (to pay taxes)
  9. 4 Grant or award Chief Operating Officer acquired 236,360 shares (grant or award)
  10. 3 Insider Initial Statement of Ownership
  11. 4 Planned sale Chief Financial Officer sold 30,000 shares at $19.09 ($572,835)
  12. 4 Planned sale Chief Financial Officer sold 30,000 shares at $15.69 ($470,622)
  13. 4 Insider Changes in Ownership
  14. 4 Shares withheld for taxes Chief Legal Officer gave up 3,309 shares (to pay taxes)
  15. 4 Shares withheld for taxes Chief Financial Officer gave up 12,336 shares (to pay taxes)
  16. 4 Shares withheld for taxes Chief Commercial Officer gave up 8,366 shares (to pay taxes)
  17. 4 Shares withheld for taxes Chief Operating Officer gave up 12,111 shares (to pay taxes)
  18. 4 Shares withheld for taxes Chief Technology Officer gave up 1,710 shares (to pay taxes)
  19. 4 Shares withheld for taxes Chief Scientific Officer gave up 308 shares (to pay taxes)
  20. 4 Shares withheld for taxes Chief Financial Officer gave up 4,517 shares (to pay taxes)

Page 9 of 65 · 1,293 filings